Share on StockTwits

Skyline Medical (NASDAQ:SKLN) major shareholder Samuel Herschkowitz bought 2,000 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was purchased at an average price of $0.12 per share, for a total transaction of $240.00. Following the purchase, the insider now directly owns 46,782,377 shares of the company’s stock, valued at approximately $5,613,885. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Skyline Medical (NASDAQ:SKLN) traded up 11.15% during mid-day trading on Thursday, hitting $0.1445. 46,700 shares of the company’s stock traded hands. Skyline Medical has a 52-week low of $0.106 and a 52-week high of $0.47. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.17. The company’s market cap is $32.1 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.